TransMedics Group, Inc. splits its revenue into 3 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Product at $111.2 million, 59% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
668
|
190
|
174
|
161
|
144
|
157
|
144
|
122
|
109
|
| Product |
407
+25.2%
share 60.9%
|
111
+15.7%
share 58.5%
|
108
+22.4%
share 62.1%
|
100
+33.9%
share 62.4%
|
88
+33.1%
share 61.0%
|
96
share 61.1%
|
88
share 61.5%
|
75
share 61.6%
|
66
share 60.6%
|
| Services |
261
+26.7%
share 39.1%
|
79
+28.6%
share 41.5%
|
66
+19.3%
share 37.9%
|
60
+29.3%
share 37.6%
|
56
+30.9%
share 39.0%
|
61
share 38.9%
|
55
share 38.5%
|
47
share 38.4%
|
43
share 39.4%
|
| Service Unrelated To OCS Transplant |
4
+4.7%
share 0.7%
|
1
+0.0%
share 0.5%
|
1
+44.4%
share 0.7%
|
1
-9.1%
share 0.6%
|
1
-7.7%
share 0.8%
|
1
share 0.6%
|
1
share 0.6%
|
1
share 0.9%
|
1
share 1.2%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- TMDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Andover, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1756262
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.